InvestorsHub Logo
Followers 35
Posts 6803
Boards Moderated 1
Alias Born 04/04/2020

Re: None

Tuesday, 01/03/2023 12:12:51 PM

Tuesday, January 03, 2023 12:12:51 PM

Post# of 426231
Question for the board's legal minds. Could this settlement be seen as solidifying the concept of insurance companies being liable for inducing infringment? Inducement when inappropriately covering "skinny label" generic drugs for patented uses. Obviously Health Net felt that there was a risk here. We don't know the details of the settlement, but a settlement of any kind would suggest that the lawyers for the defendant didn't have overwhelming confidence in their legal position. How will other insurance companies react? How will big pharma proceed when faced with "skinny label" competition?
When trying to evaluate the importance of this settlement, I think it's important to remember that this suit was the first of it's kind.
Opinions welcome.
Sleven,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News